methods for reducing weight gain or inducing weight loss, and for treating hyperglycemia, reducing blood glucose levels, or normalizing blood glucose levels.

摘要

Methods are provided for administering an extended half-life GLP-1/GIP coagonist peptide to a patient in need thereof for reducing weight gain, inducing weight loss, treating hyperglycemia, reducing blood glucose levels, or normalizing blood glucose levels in said patient.